Common variants associated with plasma triglycerides… : DASH Story 2016-12-02
Story content
I am ex-Harvard Med School Faculty (1987–1994). Worked in pharmaceutical industry for 20 years. Now I work independently with investors to build new biotech companies. It is very difficult to attract funding and investment for early stage proof of concept studies, such as repurposing of old drugs for new clinical indications. Open access is the only way for me to access some of the scientific literature to understand scientific background for this work.
Country
US